Adenoviral vector vaccines have been in development for decades, but very few have been approved for use in humans. What does the history of adenoviral vector vaccine development tell us about their ...
AstraZeneca and the University of Oxford offered a promising but confusing early look at late-stage data for their experimental adenoviral vector vaccine for COVID-19. The preliminary results suggest ...
A photo of a CanSino scientist holding a vial of its Ad5-based COVID-19 vaccine. CanSino Biologics began a clinical trial of its Ad5-based COVID-19 vaccine on March 16. Credit: CanSino Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback